Bayer to cut Ranbaxy payment to $40 m
Germany's Bayer AG will cut the milestone payments it has agreed to give India's Ranbaxy Laboratories for a once-a-day form of the anti anthrax drug Cipro to about $40 million from $55 million a
Germany's Bayer AG will cut the milestone payments it has agreed to give India's Ranbaxy Laboratories for a once-a-day form of the anti anthrax drug Cipro to about $40 million from $55 million a